$NAVB NAVIDEA BIOPHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NAVIDEA BIOPHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NAVIDEA BIOPHARMACEUTICALS, INC. for free.
IRS Number: 311080091
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NAVB
Company Address: 4995 BRADENTON AVENUE SUITE 240 DUBLIN 43017
Phone number: 6147937500
Former name: NEOPROBE CORP, date of change: 1994-07-14
Market Capitalization: $77.59M
Prev close: $0.52
Average Daily Volume: 833,077
Days Low: $0.49
Year Low: $0.26
Year High: $1.51
NAVIDEA BIOPHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Bhalla Amit | Director | Option Exercise | A | 1.64 | 2,500 | 4,100 | 2,500 | |
| May 06 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Bhalla Amit | Director | Grant | A | 0.00 | 2,500 | 3 | 2,500 | 0 to 2.5 K |
| Apr 26 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Witter Malcolm G | Director | Buy | P | 1.60 | 10,000 | 16,000 | 57,000 | 47 K to 57 K (+21.28 %) |
| Mar 29 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Witter Malcolm G | Director | Buy | P | 2.07 | 21,500 | 44,505 | 47,000 | 25.5 K to 47 K (+84.31 %) |
| Mar 04 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Scott John K Jr. | 10% Owner | Option Exercise | P | 2.30 | 50,000 | 115,000 | 50,000 | |
| Mar 03 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Witter Malcolm G | Director | Buy | P | 2.31 | 15,000 | 34,650 | 25,500 | 10.5 K to 25.5 K (+142.86 %) |
| Feb 17 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Rosol Michael Stanley | Chief Medical Offic ... | Option Exercise | A | 2.56 | 25,000 | 64,000 | 25,000 | |
| Feb 17 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Option Exercise | A | 2.56 | 100,000 | 256,000 | 100,000 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Witter Malcolm G | Director | Option Exercise | A | 2.28 | 2,500 | 5,700 | 2,500 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Witter Malcolm G | Director | Grant | A | 0.00 | 2,500 | 3 | 13,000 | 10.5 K to 13 K (+23.81 %) |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Rouan Sarah Kathryn | Director | Option Exercise | A | 2.28 | 2,500 | 5,700 | 2,500 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Rouan Sarah Kathryn | Director | Grant | A | 0.00 | 2,500 | 3 | 13,350 | 10.9 K to 13.4 K (+23.04 %) |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | RICE YEHUDA MICHAEL | Director | Option Exercise | A | 2.28 | 2,500 | 5,700 | 2,500 | |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | RICE YEHUDA MICHAEL | Director | Grant | A | 0.00 | 2,500 | 3 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Jan 14 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Cutler Adam D. | Director | Option Exercise | A | 2.28 | 2,500 | 5,700 | 2,500 |
View all NAVIDEA BIOPHARMACEUTICALS, INC. insider transactions.